TrialAntimicrobial agents and chemotherapy2011

Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.

Caralee J Schaefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.